How to Deal with Depression: From Symptoms to a Treatment Plan That Works

Depression does not feel like sadness. People often describe it differently: a flatness, a disconnection, a weight that makes ordinary things feel impossibly difficult. The things that used to bring you joy stop working. Your thinking slows or spirals. Sleeping too much or not at all. Eating too little or too much without noticing. It can feel like a problem with you, when it is actually a problem with your brain chemistry.

That distinction matters, because depression is a medical condition. It is treatable. And the gap between “managing symptoms” and “actually recovering” almost always comes down to whether treatment matches the actual clinical picture.

This guide walks through what depression is, how it is diagnosed, what evidence-based treatment looks like, and what to do when first-line treatment is not working.

What This Page Covers

• What depression actually is, and how it differs from sadness
• Common symptoms and how they are evaluated
• First-line treatments: psychotherapy and medication
• Why so many people drop off treatment and what the research shows about staying with it
• What to do when first-line treatment is not enough
• How SiggyMD supports ongoing depression care

What Depression Actually Is

Depression, also called major depressive disorder, is a medical condition that causes severe symptoms affecting how a person feels, thinks, and handles daily activities. To be diagnosed, a person must have symptoms most of the day, nearly every day, for at least two weeks.

The symptoms are broader than most people expect:

Emotional symptoms include persistent sadness, emptiness, hopelessness, or irritability. Interest or pleasure in activities that once mattered nearly disappears. This loss of interest, called anhedonia, is one of the core diagnostic features.

Physical and cognitive symptoms include fatigue, slowed thinking, difficulty concentrating, changes in appetite and weight, and disrupted sleep in either direction. Physical aches or pains without a clear physical explanation are common. Physical aches or pains, headaches, cramps, or digestive problems without a clear physical cause are documented symptoms of depression.

Thoughts about death, worthlessness, or hopelessness are part of the picture in more severe presentations. If you are experiencing thoughts of self-harm or suicide, contact the 988 Suicide and Crisis Lifeline by calling or texting 988, or go to your nearest emergency room.

According to the World Health Organization, approximately 280 million people globally live with depression. It is one of the leading causes of disability worldwide.

Why Depression Doesn’t Just “Get Better”

One of the most persistent misconceptions about depression is that it will pass on its own if you wait it out. For mild episodes, that sometimes happens. For moderate and severe depression, the evidence runs the other way. Untreated depression tends to recur, and each subsequent episode is associated with greater severity and increasing treatment resistance.

Up to 75% of patients may discontinue antidepressants within six months, making adherence support and regular follow-up essential components of successful treatment. The most common reason is feeling better. When the medication starts working, people stop taking it. Then the depression returns, often more severe. That cycle is one of the main clinical problems in depression care, and it is preventable with the right support structure.

First-Line Treatment: Psychotherapy

For mild to moderate depression, psychotherapy is the recommended starting point. Cognitive behavioral therapy is one of the most extensively researched and effective treatments for depression, helping patients identify and change negative thought patterns and behaviors that contribute to depressive symptoms.

CBT is a structured, time-limited approach. Most courses run 8 to 20 sessions. It works by addressing the cognitive distortions and behavioral patterns that sustain depression, not just the feelings. Patients who complete a full course of CBT tend to show lower relapse rates than those who responded to medication alone but stopped treatment.

Interpersonal therapy (IPT) is another evidence-based option, particularly useful for depression triggered by relationship changes, grief, or social isolation. It addresses the interpersonal patterns that interact with depressive symptoms.

Depression-focused psychotherapy, including CBT and interpersonal therapy, is considered the initial treatment method for mild to moderate major depressive disorder. For more severe presentations, combining psychotherapy with medication produces better outcomes than either alone.

First-Line Treatment: Antidepressant Medication

For moderate to severe depression, medication is part of the standard treatment protocol. Second-generation antidepressants, including SSRIs, SNRIs, and NDRIs, are recommended for the treatment of depression. The evidence base is insufficient for recommending any specific medication over another.

SSRIs (sertraline, escitalopram, fluoxetine, paroxetine) increase serotonin availability in the brain. They are the default first prescription for most patients because of their well-established safety profile and tolerability relative to older antidepressant classes.

SNRIs (venlafaxine, duloxetine) block both serotonin and norepinephrine reuptake. They are particularly useful for patients with co-occurring anxiety, chronic pain, or physical symptoms of depression.

Antidepressants take time, usually 4 to 8 weeks, to work, and problems with sleep, appetite, and concentration often improve before mood lifts. Giving a medication a full trial before concluding it is not working is clinically important. A two-week trial is not an adequate assessment.

Common early side effects of SSRIs include nausea, headache, and mild sleep changes. Most resolve within two to four weeks. Persistent side effects such as sexual dysfunction or weight changes affect a meaningful percentage of patients and should be discussed with a prescriber, who has options to address them.

Why Staying With Treatment Is the Hardest Part

Combining medications and psychotherapy offers the most effective approach for patients who do not respond to initial interventions, potentially reaching 67% remission across treatment steps. But getting there requires staying in treatment long enough.

The clinical data on depression adherence is sobering. Most people stop treatment within six months. The most common reason is not side effects. It is feeling better. When the medication begins to work, the urgency to continue disappears. That is exactly the moment when stopping creates the most risk.

Clinical guidelines generally recommend continuing antidepressants for at least six months after full remission to reduce relapse risk. For patients with two or more prior episodes, the recommended maintenance period extends further. The goal is not to take medication indefinitely. The goal is to give the brain enough time to stabilize before withdrawing support.

Lifestyle Factors That Reinforce Treatment

Evidence supports several lifestyle changes as meaningful adjuncts to clinical treatment:

Exercise. Multiple studies support the antidepressant effects of regular aerobic exercise, particularly for mild to moderate depression. Even 30 minutes three times per week shows measurable effects on mood.

Sleep. Depression and sleep disruption interact in both directions. Restoring sleep hygiene supports medication efficacy and reduces depressive symptom severity.

Social connection. Isolation reinforces depression. Involving family and social networks for psychosocial support is part of evidence-based guidelines for depression management.

Reducing alcohol use. Alcohol is a central nervous system depressant that worsens depression outcomes and interacts negatively with most antidepressants.

These changes do not replace clinical treatment for moderate-to-severe depression. They reinforce it.

When First-Line Treatment Is Not Working

If you have tried one or more antidepressants at adequate doses and durations without sufficient improvement, you are not out of options. You have entered a category called treatment-resistant depression, which has its own clinical protocol.

Common next steps include:

Augmentation. Adding a second medication to an existing antidepressant. Common options include lithium, atypical antipsychotics, or thyroid hormone in specific presentations.

Switching medication classes. If SSRIs have not worked, SNRIs, bupropion, or other classes may respond differently.

Esketamine (Spravato). FDA-approved for treatment-resistant depression, esketamine targets NMDA glutamate receptors rather than monoamine systems, producing rapid antidepressant effects within hours. It is administered in a certified healthcare setting.

TMS. Transcranial magnetic stimulation uses magnetic fields to stimulate neural circuits involved in mood regulation. TMS has been shown in large controlled studies to be consistently effective in treating treatment-resistant depression. It is non-invasive and does not require anesthesia.

Treatment-resistant depression occurs when a person doesn’t get better after trying at least two antidepressants. Treatment resistance does not mean untreatable.

How SiggyMD Approaches Depression Care

Depression management requires more than a prescription. It requires knowing how the medication is actually affecting you week by week, whether side effects are emerging, whether mood is trending in the right direction, and when the plan needs to change.

SiggyMD’s daily check-in model collects exactly that data. Mood, sleep, energy, and side effect reports build a continuous clinical record that a licensed prescriber reviews as part of ongoing care. When something is not working, the prescriber can see that within days rather than months.

“Depression has a way of making people stop when they are closest to the turning point,” says Shannon Carres, Psych P.A., of the SiggyMD clinical team. “The check-in data shows me whether someone’s mood is actually trending up even when they don’t feel it yet. That is one of the most important things I can do: keep them in treatment long enough for the treatment to work.”

For more on the medication side of depression treatment, see our complete guide to SSRIs and how doctors decide on dosing.

What Members Are Saying

MK

M.K., 37

Major Depressive Disorder

“I stopped my first antidepressant after three weeks because I felt worse. My prescriber explained that what I experienced was activation, not failure. I started again at a lower dose, got through the first month, and by week eight I felt genuinely better for the first time in years.”

JT

J.T., 29

Depression and Anxiety

“The daily check-in felt small, but it changed things. My prescriber adjusted my dose based on the sleep patterns showing up in my check-ins before my next appointment. I didn’t have to wait weeks to tell someone something wasn’t working.”

Member stories reflect real experiences. Names and identifying details have been changed to protect privacy. Results vary. SiggyMD is currently invite-only.

You Don’t Have to Figure This Out Alone

Depression makes it harder to take the steps needed to treat depression. That is part of the condition. The anonymity of SiggyMD’s intake removes several of the barriers that most commonly get in the way: no account required, no name, no email. Just an honest clinical conversation followed by a prescriber-reviewed treatment plan.

Understanding how your prescriber evaluates antidepressant response helps you stay in treatment through the window it needs. Or start your anonymous intake with SiggyMD today and talk to someone who can help you figure out what is going on and what to do about it.

Sources

1. National Institute of Mental Health. Depression. Accessed June 2026.

2. Voineskos D, et al. Major depressive disorder: Validated treatments and future challenges. World Journal of Psychiatry. 2020;10(7):27-37.

3. American Psychological Association. Depression Treatments for Adults. Clinical Practice Guideline. Accessed June 2026.

4. World Health Organization. Depressive Disorder (Depression). March 2023.

5. Park SC, et al. Evidence-Based, Non-Pharmacological Treatment Guideline for Depression in Korea. Journal of Korean Medical Science. 2014;29(1):12.

6. Medical News Today. Anxiety and depression: Which medications are best? Updated August 2025.